Compare NAMM & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAMM | KRRO |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 58.6M |
| IPO Year | N/A | 2019 |
| Metric | NAMM | KRRO |
|---|---|---|
| Price | $1.04 | $8.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 151.4K | ★ 322.3K |
| Earning Date | 04-23-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,348,000.00 | $7,371,000.00 |
| Revenue This Year | N/A | $144.83 |
| Revenue Next Year | $109.93 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.52 | N/A |
| 52 Week Low | $0.96 | $5.20 |
| 52 Week High | $55.00 | $55.89 |
| Indicator | NAMM | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 35.10 |
| Support Level | N/A | $7.73 |
| Resistance Level | N/A | $8.59 |
| Average True Range (ATR) | 0.00 | 0.57 |
| MACD | 0.00 | 0.83 |
| Stochastic Oscillator | 0.00 | 39.10 |
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.